Rep-Biotech Joint Doctoral Project is an European Network created to train the new generation of excellent researchers in the Biology and Technology of Reproductive Health (both human and animal).
Rep-Biotech Joint Doctoral Project is a Marie-Skłodowska Curie Innovative Training Network funded by the European Commission under the Horizon 2020 Programme and is composed of 12 leading academic research groups and 3 companies from 9 different countries: Spain, France, Ireland, Italy, Belgium, Germany, USA, Japan and The Netherlands.
The Network started on November 1st 2015 and will end on October 31st 2019.
To identify target molecules, culture conditions or modifications of the culture media used in ARTs with potential beneficial roles in the establishment of the correct epigenetic marks during early embryo development both in humans and animals thus contributing to the diagnosis and treatment of diseases derived from altered epigenomes.
To improve the quality and quantity of animal derived products in Europe through the development of new strategies (as described in objective 1) in ARTs, mainly the in vitro production of healthier embryos leading to healthier livestock offspring for human consumption.
To provide tools for improved reproductive efficiency in human populations, according to diverse demographic goals and strategies.
To contribute to the conservation of biodiversity in Europe by the improvement of ARTs and by increasing knowledge of, and environmental stressors affecting, the fertility of domestic and wild species.
To enhance the transfer to society of the beneficial factors identified in the previous objectives by training qualified professionals (PhD awarded) with the knowledge and entrepreneurial capacity to create innovative companies (e.g. spin-off or start-up).
To develop an efficient strategy for the dissemination of achievements and for creating awareness among the general public of their implications for citizens and society.